The ISARIC data platform: Optimizing data-driven pandemic preparedness and response

Grant number: 225288/Z/22/Z

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2024
  • Known Financial Commitments (USD)

    $1,323,398.22
  • Funder

    Wellcome Trust
  • Principal Investigator

    Ms Laura Merson
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Taking the lessons learned from the international success of ISARIC's COVID-19 data platform, we will expand the platform to answer new questions on COVID-19 and build data systems to respond to future outbreaks of infectious diseases. This collaboration brings together scientists who have developed world-leading data integration, processing and analytic technologies with health care workers and public health specialists who will use and tailor the technologies to deliver evidence that's relevant to patient care and public health policy decisions. Together we will expand the data platform to 1) integrate epidemiological and clinical data so that we can analyse research questions at an individual level and a population level; 2) integrate genomic data so that we can understand how different virus variants affect patient outcomes; and 3) provide the infrastructure to scale data processing and grow our international network to generate more evidence on emerging infectious diseases. We will analyse these integrated data sets to generate evidence on the impact of vaccination and new variants in COVID-19 infection and post-acute COVID-19 syndrome. We will also develop methods to accelerate science on the characterisation of future disease outbreaks.

Publicationslinked via Europe PMC

Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globally

Toward optimal disease surveillance with graph-based active learning.

Large-scale genomic surveillance reveals immunosuppression drives mutation dynamics in persistent SARS-CoV-2 infections

Dengue virus importation risks in Africa: a modelling study.

Public reporting guidelines for outbreak data: Enabling accountability for effective outbreak response by developing standards for transparency and uniformity

COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses.

Dynamics and ecology of a multi-stage expansion of Oropouche virus in Brazil

Routes of importation and spatial dynamics of SARS-CoV-2 variants during localized interventions in Chile.

Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation.